• Corpus ID: 44762826

Prodigiosin as anticancer drug Produced from bacteria of termite gut

@inproceedings{Gowralkar2013ProdigiosinAA,
  title={Prodigiosin as anticancer drug Produced from bacteria of termite gut},
  author={Maheswarappa Gowralkar},
  year={2013}
}
Prodigiosin, a natural red pigment produced by Serratia sp, Pseudomonas sp, Streptomyces sp and Vibrio sp . It is an alkaloid secondary metabolite with a unique tripyrrol structure. This pigment has been reported to have antibacterial, antifungal, antimalarial and antineoplastic activity. Prodigiosins are produced in more concentration by Serratia marcescens. In this study, Serratia marcescens was isolated from termite gut, identified and characterized by morphology, gram’s staining… 
No Paper Link Available
16 Citations
Highly Influential Citations
1
Background Citations
4
Methods Citations
3

Figures and Tables from this paper

16 Citations

Prodigiosin purification from Serratia marcescens M10 and its antitumor activities

Prodigiosin purified from solid fermentation of S. marcescens M10 strain showed promising anti-tumor activity in Lewis lung carcinoma induced tumors in BALB/c mice.

Red pigment produced by Zooshikella ganghwensis inhibited the growth of human cancer cell lines and MMP-1 gene expression

A red pigment produced by Zooshikella ganghwensis, was purified by solvent extraction and fractionation. The pigment was identified to be prodigiosin on the basis of spectroscopic data such as…

Prodigiosin/PU-H71 as a novel potential combined therapy for triple negative breast cancer (TNBC): preclinical insights

This is the first study to show that prodigiosin/PU-H71 combination had potent cytotoxicity on MDA-MB-231 cells; proving to play a paramount role in interfering with key signalling pathways in TNBC.

Inhibition of esophageal cancer cell line (KYSE-30) proliferation using secondary metabolites of Ephedra endophyte bacteria

The potentials of Ephedra endophyte bacteria for the inhibition of esophageal cancer cell line (KYSE-30) proliferation were investigated and MTT assay results showed that only strain A1 had a cytotoxic effect on KYSE- 30 cells.

A novel red pigment from marine Arthrobacter sp. G20 with specific anticancer activity

The antioxidant, cytotoxic and antimicrobial effects of a red pigment obtained from a marine bacterial strain were investigated and showed promising properties in the prevention and treatment of various cancers.

Sand Dune Streptomyces JB66 Native to the Great Indian Thar Desert Inhibits Multidrug-Resistant Pathogens

The efficacy of an actinomycete strain JB66 recovered from a sand dune soil from the Bikaner district of the Thar desert in inhibiting the growth of various bacterial pathogens was studied. The type…

Bacterial Pigments: The Bioactivities and as an Alternative for Therapeutic Applications

This review article highlights the various types of bacterial pigments, the latest studies on the discovery of bacterial Pigments and the therapeutic insights of theseacterial pigments which hopefully provides useful information, guidance and improvement in future study.

Pigment production by cold-adapted bacteria and fungi: colorful tale of cryosphere with wide range applications

The protective strategies and pigment production by cold-adapted bacteria and fungi, their industrial and biomedical applications, condition optimization for maximum pigment extraction as well as the challenges facing in the exploitation of cryospheric microorganisms for pigment extraction are highlighted to provide valuable information, direction, and progress in forthcoming studies.

Bacteria in Cancer Therapeutics: A Framework for Effective Therapeutic Bacterial Screening and Identification

This paper provided a four-step framework that can be used in screening and identifying bacteria with cancer therapeutic potential, including those that are uncultivable, and highlighted the need to establish and standardize quantitative methods that could be used to identify and compare bacteria with important cancer therapeutic traits.

Current trends and emerging technologies in biopigment production processes : Industrial food and health applications

Investigation of potential value added biopigment production using various types of agroindustrial by-product streams as well as presentation of efficient extraction, recovery and identification processes and technologies (employing emerging technologies such as supercritical carbon dioxide (SC-CO2)) are carried out.

References

SHOWING 1-10 OF 17 REFERENCES

Purification and characterization of prodigiosin produced by integrated bioreactor from Serratia sp. KH-95.

This downstream procedure that uses the integrated bioreactor can be applied to the direct production and purification of other prodigiosin analogues and hydrophobic alkaloid compounds from several microorganisms.

Anticancer activity of red pigment from Serratia marcescens in human cervix carcinoma.

Results suggested that the prodigiosin has strong anticancer and apoptosis activity against human cervical carcinoma cancer.

Prodigiosin from the supernatant of Serratia marcescens induces apoptosis in haematopoietic cancer cell lines

Results indicate that prodigiosin, an immunosuppressor, induces apoptosis in haematopoietic cancer cells with no marked toxicity in nonmalignant cells, raising the possibility of its therapeutic use as an antineoplastic drug.

Prodigiosin-induced apoptosis in human colon cancer cells.

Review of Prodigiosin, Pigmentation in Serratia marcescens

In present study, the production condition, physicochemical and functional characteristics, structure, genetic and gene expression, apoptosis and toxigenic effects of prodigiosin will be discussed in-order to contribute to the world of Serratia marcescens with respect to its prodigioin production property.

Prodigiosin Production by Serratia marcescens UCP 1549 Using Renewable-Resources as a Low Cost Substrate

The objective of this work was to indentify a suitable medium to simultaneously enhance S. marcescens growth and pigment production using renewable resources obtained from industrial wastes and to design a new, economically feasible medium supporting enhanced S. Marcescensgrowth and prodigiosin production.

Extracellular Vesicle Formation and Biosurfactant Production by Serratia marcescens

Pigmented and non-pigmented strains of Serratia marcescens produced extracellular vesicles and had wetting activity when grown at 30°C but not at 37°C, and wetting agent and prodigiosin (in a pigmented strain) were the main lipids of isolated vesicle.

Immunomodulating properties of prodigiosin 25-C, an antibiotic which preferentially suppresses induction of cytotoxic T cells.

Prodigiosin 25-C moderately prolonged survival of major histocompatibility (MHC)-mismatched skin grafts and potential usefulness of the antibiotic for a supplementary immunosuppressant are demonstrated.

Separation of the Prodigiosin‐Localizing Crude Vesicles Which Retain the Activity of Protease and Nuclease in Serratia marcescens

The profiles of the activities of the protease and the nuclease in the fractions were different from each other, suggesting that the two extracellular enzymes were released from the pigmented bacteria by different mechanisms.

Prodigiosin induces apoptosis of B and T cells from B-cell chronic lymphocytic leukemia

It is demonstrated that prodigiosin induces apoptosis of B-cell chronic lymphocytic leukemia (B-CLL) cells (n=32 patients) and the dose–response for the cytotoxic effect of prodigioin was analyzed in cells from 12 patients showing an IC50 of 116±25 nM.